Tango Therapeutics, Inc. (TNGX)
NASDAQ: TNGX · Real-Time Price · USD
1.310
+0.170 (14.91%)
At close: May 12, 2025, 4:00 PM
1.308
-0.002 (-0.12%)
After-hours: May 12, 2025, 4:25 PM EDT
Tango Therapeutics Market Cap
Tango Therapeutics has a market cap or net worth of $141.62 million as of May 12, 2025. Its market cap has decreased by -82.90% in one year.
Market Cap
141.62M
Enterprise Value
-38.16M
1-Year Change
-82.90%
Ranking
Category
Stock Price
$1.31
Market Cap Chart
Since April 20, 2021, Tango Therapeutics's market cap has decreased from $156.31M to $141.62M, a decrease of -9.39%. That is a compound annual growth rate of -2.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 123.24M | -62.87% |
| Dec 31, 2024 | 331.92M | -67.13% |
| Dec 29, 2023 | 1.01B | 57.94% |
| Dec 30, 2022 | 639.29M | -33.25% |
| Dec 31, 2021 | 957.76M | 512.74% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |